Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_assertion type Assertion NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_head.
- NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_assertion description "[Several publications have demonstrated that a significant proportion of uterine serous carcinomas show HER2 overexpression and/or amplification, suggesting that HER2 may be a promising therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_provenance.
- NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_assertion evidence source_evidence_literature NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_provenance.
- NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_assertion SIO_000772 24576030 NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_provenance.
- NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_assertion wasDerivedFrom befree-20150227 NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_provenance.
- NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_assertion wasGeneratedBy ECO_0000203 NP378724.RAX_LxTPHQpCb57kdb7sQCq1WLSG87AeSafa6rDg705hE130_provenance.